Improvement of Symptoms After Removal of the Essure® Contraceptive Implant

• Inclusion Criteria * :

ESSURE Group:

• woman aged 35 to 75

• patient with at least one Essure® implant

• surgical intervention planned because the patient is symptomatic: removal of the Essure® implant(s)

• planned intervention via vaginal route, laparoscopy, robotic surgery, or Transvaginal natural orifice transluminal endoscopic surgery (VNotes)

• patient having given free, informed and signed consent

Selection for MRI-PET examination:

• if the answer is "poor" or "bad" to the first question of the SF-12 pre-operatively

• no hysterectomy

• no analgesic treatment, or treatment stopped 48 hours before the examination

• no psychotropic treatment (anxiolytics, hypnotics (sleeping pills), antidepressants, mood stabilizers, neuroleptics)

• patient having given free, informed and signed consent

Control group:

• woman aged 35 to 75

• planned surgical intervention: salpingectomy with or without hysterectomy for benign indication

• planned intervention via vaginal route, laparoscopy, robotic surgery, or VNotes

• patient having given free, informed and signed consent

Selection for MRI-PET examination:

• age matching (+/- 5 years) with Essure® patients who have had an MRI-PET

• matching on surgical technique with Essure® patients who have had an MRI-PET: salpingectomy with or without hysterectomy

• no analgesic treatment, or treatment stopped 48 hours before the examination

• no psychotropic treatment (anxiolytics, hypnotics (sleeping pills), antidepressants, mood stabilizers, neuroleptics)

• patient having given free, informed and signed consent

• Exclusion Criteria * :

ESSURE Group:

• asymptomatic patient

• planned intervention by laparotomy

• patient potentially exposed to other heavy metals: wearer of metallic orthopedic equipment (hip or knee prosthesis, etc.), wearer of coronary stent, or tubal ligation clip

• inability to understand the information given

• persons deprived of liberty by a judicial or administrative decision

• people undergoing psychiatric care

• people admitted to a health or social establishment for purposes other than research

• adults subject to a legal protection measure (guardianship, curatorship)

• people not affiliated to a social security scheme or beneficiaries of a similar scheme

• person participating in another interventional research that may interfere with the research

Selection for MRI-PET examination:

• claustrophobia

• dosimetry of all radiological examinations over the past year not acceptable

Control Group :

• current pregnancy

• patient with cancer

• patient who has already had an Essure® implant removed

• patient potentially exposed to heavy metals: wearer of metallic orthopedic equipment (hip or knee prosthesis, etc.), wearer of coronary stent, or tubal ligation clip

• planned intervention by laparotomy

• inability to understand the information given

• persons deprived of liberty by a judicial or administrative decision

• people undergoing psychiatric care

• people admitted to a health or social establishment for purposes other than research

• adults subject to a legal protection measure (guardianship, curatorship)

• people not affiliated to a social security scheme or beneficiaries of a similar scheme

• person participating in another interventional research that may interfere with the research

Selection for MRI-PET examination:

• claustrophobia

• dosimetry of all radiological examinations over the past year not acceptable